Hyungsuk Kim
Hyungsuk Kim
Associate Professor, Kwangwoon University, Seoul, Korea
Verified email at kw.ac.kr
Title
Cited by
Cited by
Year
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...
The Lancet 387 (10027), 1540-1550, 2016
43612016
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
AT Shaw, DW Kim, K Nakagawa, T Seto, L Crinó, MJ Ahn, T De Pas, ...
New England Journal of Medicine 368 (25), 2385-2394, 2013
33462013
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
N Engl j Med 371, 2167-2177, 2014
26092014
Muon recontruction performance of the ATLAS detector in proton–proton colliion data at $$\qrt {} $$= 13 TeV
G Aad, B Abbott, J Abdallah, B Abeloos, R Aben, M Abolins, OS AbouZeid, ...
The European Physical Journal C 76 (5), 292, 2016
21862016
Study of the spin and parity of the Higgs boson in diboson decays with the ATLAS detector
G Aad, B Abbott, J Abdallah, R Aben, M Abolins, OS AbouZeid, ...
The European Physical Journal C 75 (10), 1-36, 2015
2105*2015
AZD9291 in EGFR inhibitor–resistant non–small-cell lung cancer
PA Jänne, JCH Yang, DW Kim, D Planchard, Y Ohe, SS Ramalingam, ...
New England Journal of Medicine 372 (18), 1689-1699, 2015
17392015
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a …
H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ...
The lancet oncology 15 (11), 1224-1235, 2014
16622014
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ...
The Lancet 379 (9829), 1879-1886, 2012
15202012
Electron and photon energy calibration with the ATLAS detector using LHC Run 1 data
L Allison, A Barton, M Beattie, G Borissov, E Bouhova-Thacker, ...
European Physical Journal C: Particles and Fields 74 (10), 2014
14532014
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
J Weber, M Mandala, M Del Vecchio, HJ Gogas, AM Arance, CL Cowey, ...
New England Journal of Medicine 377 (19), 1824-1835, 2017
12692017
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
S Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...
New England Journal of Medicine 377 (9), 829-838, 2017
12522017
Predictive and prognostic impact of epidermal growth factor receptor mutation in non–small-cell lung cancer patients treated with gefitinib
SW Han, TY Kim, PG Hwang, S Jeong, J Kim, IS Choi, DY Oh, JH Kim, ...
Journal of clinical oncology 23 (11), 2493-2501, 2005
9352005
Constraints on the spin-parity and anomalous couplings of the Higgs boson in proton collisions at 7 and 8 TeV
V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, T Bergauer, ...
Physical Review D 92 (1), 012004, 2015
8532015
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim, DW Kim, JY Chung, SG Shin, SC Kim, DS Heo, NK Kim, YJ Bang
Clinical cancer research 10 (11), 3708-3716, 2004
8132004
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled …
K Park, EH Tan, K O'Byrne, L Zhang, M Boyer, T Mok, V Hirsh, JCH Yang, ...
The Lancet Oncology 17 (5), 577-589, 2016
7642016
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
SC Kim, DW Kim, YH Shim, JS Bang, HS Oh, SW Kim, MH Seo
Journal of Controlled Release 72 (1-3), 191-202, 2001
7632001
Search for the b b decay of the Standard Model Higgs boson in associated (W/Z) H production with the ATLAS detector
L Allison, A Barton, M Beattie, G Borissov, E Bouhova-Thacker, ...
Journal of High Energy Physics 2015 (1), 2015
620*2015
Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study
SHI Ou, JS Ahn, L De Petris, R Govindan, JCH Yang, B Hughes, H Lena, ...
Journal of clinical oncology 34 (7), 661-668, 2016
5762016
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
D Planchard, B Besse, HJM Groen, PJ Souquet, E Quoix, CS Baik, ...
The Lancet Oncology 17 (7), 984-993, 2016
5572016
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee, KM Lee, DW Kim, DS Heo
The Journal of Immunology 172 (12), 7335-7340, 2004
5472004
The system can't perform the operation now. Try again later.
Articles 1–20